Editas Medicine, Inc. (EDIT)
2.705
+0.06
(+2.08%)
USD |
NASDAQ |
Sep 11, 15:43
Editas Medicine Gross Profit (TTM) : 44.58M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.58M |
| March 31, 2026 | 34.85M |
| December 31, 2025 | 35.24M |
| September 30, 2025 | 40.53M |
| June 30, 2025 | 32.17M |
| March 31, 2025 | 29.52M |
| December 31, 2024 | 26.50M |
| September 30, 2024 | 55.86M |
| June 30, 2024 | 61.22M |
| March 31, 2024 | 63.48M |
| December 31, 2023 | 72.06M |
| September 30, 2023 | 18.44M |
| June 30, 2023 | 13.05M |
| March 31, 2023 | 16.47M |
| December 31, 2022 | 13.37M |
| September 30, 2022 | 19.37M |
| June 30, 2022 | 20.94M |
| March 31, 2022 | 16.17M |
| December 31, 2021 | 10.96M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.083M |
| September 30, 2015 | -0.083M |
| June 30, 2015 | -0.083M |
| March 31, 2015 | -0.083M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -48.49M |
| Geron Corp. | 197.30M |
| Halozyme Therapeutics, Inc. | 1.271B |
| Novavax, Inc. | 325.46M |
| AVITA Medical, Inc. | 61.68M |